Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
30 employees
Developing pharmaceuticals and medical devices for eye care, including contract services. Founded in 2006, based in Tampa.
HQ
Founded
2006
Sirion Holdings, founded in 2006 and based in Tampa, develops pharmaceuticals and medical devices for the ophthalmic market. The company focuses on treating sight-threatening and debilitating eye diseases. It also offers contract services, including clinical, regulatory, consulting, and medical education services tailored to ophthalmology.
Sirion Holdings has made significant strides in the eye care industry, contributing to advancements in treating various eye conditions. The company's impact is marked by its innovative products and comprehensive services, enhancing patient outcomes and supporting the ophthalmic community.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Medical Devices, Pharmaceuticals
Technology
Biotech
Tags
Healthtech
Model Types
Professional Services, Software
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Sirion Holdings founded?
Sirion Holdings was founded in 2006.
Where is Sirion Holdings's headquarters located?
Sirion Holdings's headquarters is located in Tampa, FL, US.
When was Sirion Holdings's last funding round?
Sirion Holdings's most recent funding round was for $27.7M (USD) in October 2009.
How many employees does Sirion Holdings have?
Sirion Holdings has 30 employees as of Feb 5, 2024.
How much has Sirion Holdings raised to-date?
As of July 05, 2023, Sirion Holdings has raised a total of $29.2M (USD) since Oct 22, 2009.
Add Comparison
Total Raised to Date
$29.2M
USD
Last Update Oct 22, 2009
Last Deal Details
$27.7M
USD
Oct 22, 2009
Series Unknown
Current Employees
30
Last updated: Feb 5, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts